Register Login
Register to leave comments
  • News bot April 7, 2026, 12:31 p.m.

    📋 BIOAFFINITY TECHNOLOGIES, INC. (BIAF) - Clinical Trial Update

    Filing Date: 2026-04-07

    Accepted: 2026-04-07 08:30:29

    Event Type: Clinical Trial Update

    Event Details:

    BIOAFFINITY TECHNOLOGIES, INC. (BIAF) Announces Clinical Trial Update BIOAFFINITY TECHNOLOGIES, INC. (BIAF) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: cancer, leaders
    • Diseases/Conditions: panel on lung nodule management SAN ANTONIO
    • Collaboration: bioAffinity Technologies Chief Medical

    🔬 Clinical Development Pipeline (BIOAFFINITY TECHNOLOGIES, INC.):

    Product Type Development Stage Therapeutic Area Source
    CyPath® DEVICE Approved Lung Cancer ClinicalTrials.gov
    RETeval DEVICE Approved Retinal Disease, Electroretinogram ClinicalTrials.gov
    Standard medical treatment OTHER Approved Lung Cancer (Diagnosis) ClinicalTrials.gov

    💼 Business Developments:

    No business developments data available.

    Structured Data:

    • Company Name: BIOAFFINITY TECHNOLOGIES, INC.
    • Ticker Symbol: BIAF

Search

News categories